Process View
Any process that stops, prevents or reduces the frequency, rate or extent of anoikis.
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "negative regulation of anoikis"
Name | Description | Probability | Func Analog Organism | |
---|---|---|---|---|
ITGB1 | integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12) | 1.000 | ||
CEACAM6 | carcinoembryonic antigen-related cell adhesion molecule 6 (non-specific cross reacting antigen) | 0.999 | Human | |
BCL2 | B-cell CLL/lymphoma 2 | 0.996 | ||
FHL2 | four and a half LIM domains 2 | 0.996 | ||
ITGB3 | integrin, beta 3 (platelet glycoprotein IIIa, antigen CD61) | 0.990 | ||
FYN | FYN oncogene related to SRC, FGR, YES | 0.971 | Human | |
BAX | BCL2-associated X protein | 0.912 | Human | |
CEACAM1 | carcinoembryonic antigen-related cell adhesion molecule 1 (biliary glycoprotein) | 0.911 | Human | |
PSG9 | pregnancy specific beta-1-glycoprotein 9 | 0.873 | Human | |
BCL2L11 | BCL2-like 11 (apoptosis facilitator) | 0.835 | ||
SRC | v-src sarcoma (Schmidt-Ruppin A-2) viral oncogene homolog (avian) | 0.813 | ||
FN1 | fibronectin 1 | 0.808 | ||
WAS | Wiskott-Aldrich syndrome (eczema-thrombocytopenia) | 0.803 | ||
BCL2L1 | BCL2-like 1 | 0.791 | ||
CDC42 | cell division cycle 42 (GTP binding protein, 25kDa) | 0.778 | ||
PTPN1 | protein tyrosine phosphatase, non-receptor type 1 | 0.654 | ||
SYK | spleen tyrosine kinase | 0.651 | ||
PSG6 | pregnancy specific beta-1-glycoprotein 6 | 0.597 | Human | |
BID | BH3 interacting domain death agonist | 0.538 | ||
PXN | paxillin | 0.419 | ||
PIK3R1 | phosphoinositide-3-kinase, regulatory subunit 1 (alpha) | 0.409 | ||
LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 0.373 | ||
CAV1 | caveolin 1, caveolae protein, 22kDa | 0.350 | ||
ERBB3 | v-erb-b2 erythroblastic leukemia viral oncogene homolog 3 (avian) | 0.330 | ||
PTK2 | PTK2 protein tyrosine kinase 2 | 0.261 | ||
MCL1 | myeloid cell leukemia sequence 1 (BCL2-related) | 0.206 | ||
PSG4 | pregnancy specific beta-1-glycoprotein 4 | 0.195 | ||
SFN | stratifin | 0.183 | ||
CEACAM5 | carcinoembryonic antigen-related cell adhesion molecule 5 | 0.182 | ||
LCK | lymphocyte-specific protein tyrosine kinase | 0.181 | Human | |
BAD | BCL2-associated agonist of cell death | 0.159 | ||
ENG | endoglin | 0.147 | ||
PTPRC | protein tyrosine phosphatase, receptor type, C | 0.144 | ||
LATS2 | LATS, large tumor suppressor, homolog 2 (Drosophila) | 0.140 | ||
JAG1 | jagged 1 | 0.136 | ||
PSG5 | pregnancy specific beta-1-glycoprotein 5 | 0.123 | Human | |
BCAR1 | breast cancer anti-estrogen resistance 1 | 0.120 | ||
PDIA3 | protein disulfide isomerase family A, member 3 | 0.108 | ||
EPS8 | epidermal growth factor receptor pathway substrate 8 | 0.098 | ||
SPRR2A | small proline-rich protein 2A | 0.088 | ||
FLNA | filamin A, alpha | 0.083 | ||
BAK1 | BCL2-antagonist/killer 1 | 0.081 | Human | |
PSG3 | pregnancy specific beta-1-glycoprotein 3 | 0.080 | ||
IRS1 | insulin receptor substrate 1 | 0.079 | ||
PSTPIP1 | proline-serine-threonine phosphatase interacting protein 1 | 0.078 | ||
ITGB2 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) | 0.078 | Human | |
ITGA6 | integrin, alpha 6 | 0.077 | Human | |
CEACAM7 | carcinoembryonic antigen-related cell adhesion molecule 7 | 0.062 | Human | |
FHL3 | four and a half LIM domains 3 | 0.058 | ||
CRK | v-crk sarcoma virus CT10 oncogene homolog (avian) | 0.051 | ||
MYO10 | myosin X | 0.050 | ||
CYTH1 | cytohesin 1 | 0.049 | ||
AR | androgen receptor | 0.046 | ||
PLEC | plectin | 0.043 | ||
ITGA3 | integrin, alpha 3 (antigen CD49C, alpha 3 subunit of VLA-3 receptor) | 0.043 | Human | |
HCK | hemopoietic cell kinase | 0.042 | Human | |
ITGAL | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) | 0.040 | Human | |
MMP14 | matrix metallopeptidase 14 (membrane-inserted) | 0.039 | ||
PSG1 | pregnancy specific beta-1-glycoprotein 1 | 0.039 | ||
IBTK | inhibitor of Bruton agammaglobulinemia tyrosine kinase | 0.038 | ||
CEACAM8 | carcinoembryonic antigen-related cell adhesion molecule 8 | 0.036 | Human | |
PMAIP1 | phorbol-12-myristate-13-acetate-induced protein 1 | 0.034 | ||
CRKL | v-crk sarcoma virus CT10 oncogene homolog (avian)-like | 0.032 | ||
DLL1 | delta-like 1 (Drosophila) | 0.032 | ||
MED28 | mediator complex subunit 28 | 0.032 | ||
SH3KBP1 | SH3-domain kinase binding protein 1 | 0.031 | ||
JUB | jub, ajuba homolog (Xenopus laevis) | 0.030 | ||
EGFR | epidermal growth factor receptor | 0.029 | ||
ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.029 | ||
YES1 | v-yes-1 Yamaguchi sarcoma viral oncogene homolog 1 | 0.028 | Human | |
NOTCH1 | notch 1 | 0.027 | ||
MATK | megakaryocyte-associated tyrosine kinase | 0.027 | ||
ICAM1 | intercellular adhesion molecule 1 | 0.026 | ||
PTPRF | protein tyrosine phosphatase, receptor type, F | 0.025 | ||
PDCD6IP | programmed cell death 6 interacting protein | 0.025 | ||
WIPF1 | WAS/WASL interacting protein family, member 1 | 0.022 | ||
ITGB5 | integrin, beta 5 | 0.022 | Human | |
ITGB4 | integrin, beta 4 | 0.021 | Human | |
CAV2 | caveolin 2 | 0.020 | Human | |
SRCIN1 | SRC kinase signaling inhibitor 1 | 0.020 | ||
MET | met proto-oncogene (hepatocyte growth factor receptor) | 0.020 | ||
COL17A1 | collagen, type XVII, alpha 1 | 0.019 | ||
SGK3 | serum/glucocorticoid regulated kinase family, member 3 | 0.019 | ||
NCK1 | NCK adaptor protein 1 | 0.018 | ||
CLTC | clathrin, heavy chain (Hc) | 0.018 | ||
PRKCB | protein kinase C, beta | 0.017 | ||
CD22 | CD22 molecule | 0.017 | ||
ANGPTL4 | angiopoietin-like 4 | 0.017 | ||
CMIP | c-Maf-inducing protein | 0.017 | ||
PTEN | phosphatase and tensin homolog | 0.017 | ||
CLEC4M | C-type lectin domain family 4, member M | 0.017 | ||
TNS4 | tensin 4 | 0.016 | ||
NTF4 | neurotrophin 4 | 0.016 | ||
ANXA1 | annexin A1 | 0.016 | ||
PSG7 | pregnancy specific beta-1-glycoprotein 7 (gene/pseudogene) | 0.016 | ||
RBPJ | recombination signal binding protein for immunoglobulin kappa J region | 0.015 | ||
MUC1 | mucin 1, cell surface associated | 0.015 | ||
VCAM1 | vascular cell adhesion molecule 1 | 0.015 | ||
CALD1 | caldesmon 1 | 0.015 | ||
F2R | coagulation factor II (thrombin) receptor | 0.014 | ||
GRB2 | growth factor receptor-bound protein 2 | 0.014 | ||
TENC1 | tensin like C1 domain containing phosphatase (tensin 2) | 0.014 | ||
ITGA2 | integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor) | 0.014 | Human | |
FCGR2A | Fc fragment of IgG, low affinity IIa, receptor (CD32) | 0.014 | ||
VAV1 | vav 1 guanine nucleotide exchange factor | 0.014 | ||
FAS | Fas (TNF receptor superfamily, member 6) | 0.014 | ||
CTGF | connective tissue growth factor | 0.014 | ||
PSEN2 | presenilin 2 (Alzheimer disease 4) | 0.013 | ||
ITGAX | integrin, alpha X (complement component 3 receptor 4 subunit) | 0.013 | ||
NOTCH2NL | notch 2 N-terminal like | 0.013 | ||
LAMC1 | laminin, gamma 1 (formerly LAMB2) | 0.013 | ||
ALAS1 | aminolevulinate, delta-, synthase 1 | 0.013 | ||
HPS6 | Hermansky-Pudlak syndrome 6 | 0.013 | ||
PTPN6 | protein tyrosine phosphatase, non-receptor type 6 | 0.013 | ||
CD79A | CD79a molecule, immunoglobulin-associated alpha | 0.012 | ||
RNF144B | ring finger protein 144B | 0.012 | ||
NCF4 | neutrophil cytosolic factor 4, 40kDa | 0.012 | ||
GAS7 | growth arrest-specific 7 | 0.012 | ||
PLAUR | plasminogen activator, urokinase receptor | 0.011 | ||
TLN1 | talin 1 | 0.011 | ||
PSG2 | pregnancy specific beta-1-glycoprotein 2 | 0.011 | ||
TRAF3IP3 | TRAF3 interacting protein 3 | 0.010 |